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Abstract
Background: ECG changes after revascularization predicts improved outcome for pa-
tients	with	ST-elevation	myocardial	infarction	(STEMI).	Worst	lead	residual	(WLR)	ST	
deviation	and	resolution	of	worst	lead	ST	elevation	(rST	elevation)	are	simple	meas-
ures that can be obtained early after PCI. The objective of the current study was to 
investigate whether simple ECG measures, obtained one hour following PCI, could 
predict	cardiac	magnetic	 resonance	 (CMR)-derived	myocardial	 salvage	 index	 (MSI),	
infarct	size	(IS),	and	microvascular	obstruction	(MVO)	in	patients	with	STEMI	included	
in	the	MITOCARE	trial.
Methods: The	MITOCARE	 trial	 included	165	patients	with	a	 first-time	STEMI	pre-
senting	within	 six	hours	of	 symptom	onset.	The	current	 analysis	 included	patients	
that	had	an	ECG	recorded	at	baseline	and	one	hour	after	PCI	and	underwent	CMR	
imaging after 3–5 days. Independent core laboratories determined WLR ST deviation, 
rST	elevation,	and	the	CMR	variables	(MSI,	IS,	and	MVO).
Results: 83	patients	with	a	mean	age	of	61	years	were	included.	83.1%	were	males	











rarely utilized in clinical practice when treating patients with ST-
elevation	myocardial	infarction	(STEMI).
ST-segment	 resolution	 on	 the	 electrocardiogram	 (ECG)	 is	 a	
marker of reperfusion and begins to occur immediately after re-
establishment of coronary blood flow to an ischemic area. Early 
ST-segment resolution predicts improved outcome and has been 
shown to be associated with final infarct size (Buller et al., 2008; 
van 't Hof, Liem, de Boer, & Zijlstra, 1997; Kim et al., 2008; Schroder, 
Wegscheider,	 Schroder,	 Dissmann,	 &	 Meyer-Sabellek,	 1995).	 A	
previous	study	on	STEMI	patients	supports	that	different	metrics	
of ST-segment recovery predict infarct size and ejection fraction 
evaluated	with	CMR	at	 four	months	 after	 the	 infarction	 (Hallén,	
Sejersten,	 Johanson,	 Atar,	 &	 Clemmensen,	 2010).	 In	 their	 work,	
Hallén	et	al.	found	that	worst	lead	residual	(WLR)	ST-segment	de-
viation, which is easily obtained from an ECG following reperfu-
sion, performed equal to or better than more advanced measures 
of ST-segment resolution in patients treated with primary percu-
taneous	 coronary	 intervention	 (PCI).	 In	 the	MITOCARE	 project,	
core laboratories assessed protocol-specified observations from 
ECGs	and	CMR	images	 in	patients	with	STEMI	(Atar	et	al.,	2015;	
Mitocare	Study	Group,	2012).
In the present substudy, we aimed to investigate whether WLR 
ST deviation and resolution of worst lead ST elevation (rST eleva-
tion)	 at	 one	 hour	 after	 revascularization	 could	 predict	 myocardial	
salvage	index	(MSI),	IS,	and	MVO	obtained	by	CMR	after	3–5	days.
2  | MATERIAL AND METHODS
2.1 | Patient population
The	MITOCARE	study	was	a	multi-center,	randomized	trial	evaluat-
ing the efficacy and safety of TRO40303 for the reduction of rep-
erfusion	 injury	 in	165	patients	undergoing	primary	PCI	for	STEMI.	
TRO40303 did not show any significant effect on reperfusion injury 
(Atar	 et	 al.,	 2015).	All	 subjects	 had	 a	 first-time	 STEMI	 (defined	 as	
nitrate-resistant pain for at least 30 min and new ST elevation at 
J-point	 in	 two	contiguous	 leads	with	standard	cut-off	points),	pre-
senting	within	6	hr	of	the	onset	of	chest	pain	and	had	occlusion	of	
the	culprit	artery	 (Mitocare	Study	Group,	2012).	Patients	were	 in-
cluded in the current analysis if they had an ECG recorded at base-
line	and	one	hour	after	PCI	and	underwent	CMR	imaging	3–5	days	
after their event. Patients were not considered if the ECGs showed 
significant confounders (defined as ventricular pacing, ventricular 
rhythm	or	LBBB)	or	 if	 the	CMR	 investigation	was	 incomplete.	The	
study complies with the Declaration of Helsinki and was approved 
by regulatory agencies and local ethics committees. All patients pro-
vided written informed consent.
2.2 | ECG analysis
ECG analyses were performed by an ECG core laboratory at 
Rigshospitalet	(Copenhagen,	Denmark),	by	investigators	blinded	to	all	
patient	data	(Sejersten	et	al.,	2017).	For	the	current	study,	standard	
12-lead ECGs recorded at baseline and one hour after revasculariza-
tion were used. ST-segment deviation from the TP segment was meas-
ured manually to the nearest 0.5 mm at the J-point in all 12 leads. If 
the TP segment was not distinct, the PR segment was used as the 
isoelectric line. For the current study, two ECG measures were as-
sessed. WLR ST deviation was defined as the absolute mm magnitude 
of residual ST deviation in the most affected lead on the one-hour 
ECG, without reference to the baseline ECG. In addition, rST eleva-
tion was calculated from baseline and one-hour ECG, using the worst 
lead ST elevation at baseline, and the same lead at the one-hour ECG 
(reported	as	resolution	relative	to	the	ST	elevation	at	baseline).
2.3 | Cardiovascular magnetic resonance imaging
In	the	MITOCARE	study,	the	main	secondary	endpoint	was	the	MSI,	
calculated	from	CMR	measures	of	IS	and	myocardium	at	risk.	CMR	
images were obtained 3–5 days after revascularization using whole-
body 1.5T magnetic resonance scanners with ECG-gated image ac-
quisition.	 All	 CMR	 analyses	were	 performed	 by	 a	 core	 laboratory	
(Imacor	AB,	Lund,	Sweden),	blinded	to	clinical	data.	Measures	of	left	
ventricular ejection fraction, IS (as percentage of left ventricular vol-
ume),	MSI	 ((1-IS)/myocardium	at	 risk),	 and	MVO	 (as	percentage	of	
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Conclusion: WLR	ST	deviation	one	hour	after	PCI	was	a	predictor	of	 IS	and	MVO.	
WLR ST deviation, a measure easily obtained from ECGs following PCI, may provide 
important	prognostic	information	in	patients	with	STEMI.
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Continuous variables are presented as mean (SD)	or	median	(range)	
as	appropriate.	IS,	MSI,	and	MVO	were	dichotomized	using	median	
values, and separate logistic regression models were applied to as-
sess the associations between the ECG variables and the dichoto-
mized	 CMR	 variables.	 WLR	 ST	 deviation	 and	 rST	 elevation	 were	
treated as continuous variables in all regression models. Results are 
reported	as	odds	ratios	(OR)	with	95%	confidence	intervals	(CI)	and	
p-values < .05 were considered statistically significant. All statistical 
analyses	were	performed	using	IBM	SPSS	statistics	version	26.
3  | RESULTS
83 patients with valid ECGs at baseline and one hour after PCI and 
complete	 CMR	 studies	were	 included.	 64	 patients	were	 excluded	
due	 to	 lack	of	 analyzable	CMR	 images,	 three	due	 to	 lacking	base-
line ECGs, seven due to lacking or confounded one hour ECGs, and 
eight	due	 to	missing	both	CMR	and	ECG	data.	The	characteristics	
of evaluated patients in comparison with the total study population 
are reported in Table 1. The mean age for the included patients was 
61	years.	83.1%	were	male	and	41%	had	anterior	myocardial	infarc-
tions.	The	median	WLR	ST	deviation	was	1	mm	(0–6	mm),	and	the	
median	 rST	elevation	was	0.75	 (−1.0	 to	1.25).	Values	 for	 the	CMR	
variables are presented in Table 2.







We found that WLR ST deviation was predictive of IS evaluated by 
CMR	after	3–5	days,	while	rST	elevation	trended	toward	statistical	
significance.	A	previous	report	by	Hallén	et	al,	 supports	 that	WLR	
ST deviation and single lead ST resolution predict IS obtained by 
CMR	 (Hallén	et	al.,	2010).	 In	 their	 study,	 they	 found	 that	WLR	ST	
deviation	had	great	performance	in	predicting	IS	obtained	by	CMR	
four months after revascularization. Late gadolinium enhancement 
CMR	images	are	currently	considered	the	best	in	vivo	measure	of	IS	
(Ibanez	et	al.,	2019).	Interestingly,	recent	data	indicate	that	assess-
ment of IS as early as 3–5 days after infarction predicts all-cause 
mortality	and	heart	failure	hospitalization	(de	Waha	et	al.,	2017).	The	
TA B L E  1  Descriptives	in	ECG/CMR	population	and	total	
MITOCARE	population
ECG/CMR 
population (n = 83)
Total study 
population (n = 165)


































0 or 1 10.8% 9.8%







*n = 81. 
**n = 151. 
†n	=	76.	
‡n = 148. 
TA B L E  2  Median	values	for	CMR	variables	(n	=	83)
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association between WLR ST deviation and IS in our study are fur-
ther supported by a paper by Rommel et al., reporting a significant 
association	 between	CMR	evaluated	 IS	 at	 1–4	days	 after	 PCI	 and	
residual	worst	 lead	 ST	 elevation	 (Rommel	 et	 al.,	 2014).	 In	 the	 lat-
ter study, residual ST elevation also showed a significant association 
with a combined clinical endpoint.
4.2 | Microvascular obstruction
MVO	is	defined	as	absent	or	inadequate	myocardial	perfusion	de-
spite successful epicardial reperfusion (Allencherril et al., 2019; 
van	 Kranenburg	 et	 al.,	 2014).	 This	 has	 been	 associated	with	 re-
duced	 left	 ventricular	 function	 evaluated	 by	 CMR	 at	 follow-up	
(Nijveldt	et	al.,	2008),	 and	adverse	clinical	outcome	 (Allencherril	
et	 al.,	 2019).	A	 previous	 study	 comparing	 dynamic	ECG	 changes	
between	patients	with	and	without	MVO	found	that	patients	with	
MVO	had	a	higher	single	lead	maximum	ST	elevation	before	PCI,	
while at one hour after PCI there was only a trend toward a signifi-
cant	 association	 (Weaver	et	 al.,	 2011).	Repeated	ECGs	after	PCI	
showed	 an	 increasing	 correlation	 between	 MVO	 and	 maximum	
ST elevation, suggesting that the optimal timing for measuring re-
sidual	ST	elevation	was	48–72	hr	post-PCI	 (Weaver	et	al.,	2011).	
In the current study, we found a significant association between 
WLR	ST	deviation	one	hour	after	PCI	and	MVO,	but	not	 for	 rST	
elevation	 and	 MVO.	 Compared	 with	Weaver	 et	 al.,	 the	 current	
study	 included	more	 patients,	which	may	 explain	 the	 significant	
association found for WLR ST deviation at one hour after PCI in 
our	 study.	While	 the	 association	 between	MVO	and	 residual	 ST	
elevation might appear stronger later in the clinical course, the 
use of an earlier ECG measurement for risk prediction may have 
important clinical implications.
4.3 | Myocardial salvage index
There was no statistically significant association between WLR ST 
deviation	 or	 rST	 elevation	 and	MSI	 in	 the	 current	 study.	 Previous	
analyses have compared myocardium at risk or myocardial salvage 
to more advanced ECG scores based on pre-PCI ECGs and found 
significant	associations	(Schoos	et	al.,	2013;	Sejersten	et	al.,	2017).	
Residual ST elevation after revascularization is thought to repre-
sent impaired myocardial reperfusion at the microcirculatory level 
(Claeys	et	al.,	1999;	van	't	Hof	et	al.,	1997)	and	does	not	necessarily	
reflect the volume of myocardium at risk before revascularization 
(McLaughlin	et	al.,	2004).	While	it	may	be	presumed	that	rST	eleva-
tion	have	a	stronger	association	with	MSI	 than	WLR	ST	deviation,	
neither of the variables showed a statistically significant relation-
ship	to	MSI.	 It	 is	possible	that	a	more	comprehensive	ECG	scoring	
is needed to reflect the myocardium at risk, and hence the result-





we believe that there are distinct differences between the two stud-
ies. While we measured residual ST deviation at one hour, Rommel 
et al. evaluated only residual ST elevation. Also, myocardium at risk 
and	hence	MSI	were	assessed	differently,	as	we	applied	a	contrast-
enhanced steady-state free precession sequence instead of a T2-
weighted triple inversion-recovery sequence (Atar et al., 2015; Eitel 
et	al.,	2013;	Rommel	et	al.,	2014).	In	addition,	the	AIDA	STEMI	trial	
included patients up to 12 hr after pain onset, resulting in a longer 
median	 time	 to	 treatment	 (Atar	et	al.,	2015;	Rommel	et	al.,	2014).	
How these differences affect the relationship between WLR ST de-
viation	and	MSI	warrant	further	investigation.
4.4 | Strengths and limitations
The main strengths of the current study are the prespecified ECG 
and	CMR	analyses	performed	by	core	laboratories.	WLR	ST	devia-
tion is easily obtainable in clinical practice, and few patients are 
excluded	 due	 to	 confounders	 in	 ECG.	 A	 limitation	 of	 our	 study	
is	 that	 some	 participants	were	 not	 available	 for	 complete	 CMR	
examinations.	This	 reduced	the	number	of	patients	 in	our	study	
and	could	limit	the	external	validity	of	our	findings.	However,	the	
included patients had similar baseline characteristics compared 
with	the	total	population	 (Table	1).	Furthermore,	 the	difficulties	
of	obtaining	CMR	images	in	clinical	practice	underscores	the	need	
for more simple tools for risk stratification of patients after suc-
cessful PCI.
CMR variable
Odds ratio (95% CI) with increasing 
WLR ST deviation











lead ST elevation; WLR, Worst lead residual.
TA B L E  3   Univariate logistic regression 
for	prediction	of	CMR	variables	(n	=	83)
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5  | CONCLUSIONS
WLR	ST	deviation	was	a	significant	predictor	of	IS	and	MVO,	while	
rST elevation trended toward a significant association with IS. 
Measures	of	WLR	ST	deviation	obtained	 from	ECGs	obtained	one	
hour following PCI may provide important prognostic information in 
patients	with	STEMI.
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